Methyl 3-amino-3-(2-methylphenyl)propanoate hydrochloride, 95%, 1g

(E)-1-(3,5-Dimethoxystyryl)-2,4-dimethoxybenzene, 95.0%, 100mg

ETHYL 4-METHYL-3-OXO-1,2,3,4-TETRAHYDROPYRIDO[2,3-B]PYRAZINE-2-CARBOXYLATE, 97.0%, 250mg

1-[(benzyloxy)carbonyl]-3-hydroxypyrrolidine-2-carboxylic acid, 250mg

4-Nitrophenethyl alcohol, 97.0%, 50g

Recipiente de cristalización DURAN® con pico, 60 ml, 60 mm, 10 Unidad(es)

1-Ethyl-4-piperidone>98.0%(GC)(T)25mL

3,5-Di-tert-butylbenzaldehyde, 95.0%, 5g

2-Butanone, 4-[4-(b-D-glucopyranosyloxy)phenyl]-, 500g

Methyl 2-(aminomethyl)nicotinate hydrochloride, 97.0%, 5g

2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-6-carboxylic acid, 97%, 250mg

2-(2,4-Bis(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

Tridecan-2-one, 95.0%, 5g